glucosamine has been researched along with Genetic Predisposition in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heianza, Y; Li, X; Li, Y; Liang, Z; Ma, H; Qi, L; Sun, D; Zhou, T | 1 |
| Akar, S; Akkoc, N; Birlik, M; Onen, F; Sari, I | 1 |
2 other study(ies) available for glucosamine and Genetic Predisposition
| Article | Year |
|---|---|
Glucosamine Use, Inflammation, and Genetic Susceptibility, and Incidence of Type 2 Diabetes: A Prospective Study in UK Biobank.
Topics: Adult; Aged; Aged, 80 and over; Biological Specimen Banks; C-Reactive Protein; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Follow-Up Studies; Genetic Predisposition to Disease; Glucosamine; Humans; Incidence; Inflammation; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; United Kingdom; Young Adult | 2020 |
M694V mutation may have a role in susceptibility to ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Diclofenac; Drug Combinations; Female; Follow-Up Studies; Genetic Predisposition to Disease; Glucosamine; Gout Suppressants; Homozygote; Humans; Inflammation; Male; Mutation; Radiography; Spondylitis, Ankylosing; Sulfasalazine; Time Factors; Treatment Outcome; Young Adult | 2009 |